Intelligence Feed

Longevity peptides are starting to sound like expensive multivitamins with better marketing. A few promising mouse studies and tiny human trials somehow become “reverse aging” online, while sleep, exercise, and blood pressure get treated like boring side quests. I’m not saying the research is useless, but calling every new peptide a fountain of youth is doing a lot of heavy lifting.

Rapamycin for longevity: promising geroscience or just trendy immunosuppression?

mTOR inhibition is not a free longevity upgrade; the rapamycin hype keeps ignoring dose, timing, immune effects, and whether healthy humans actually benefit. Mechanism ≠ outcome.

The longevity stack is mostly expensive ways to discover you should sleep—now with a peptide protocol and a spreadsheet proving it.